Search
Patexia Research
Case number 1:20-cv-00003

Celgene Corporation v. Mylan Pharmaceuticals Inc. et al > Summary

Court Case Number 1:20-cv-00003

Filing Date Jan 3, 2020

Termination Date Jul 23, 2021

Court West Virginia Northern District Court

Status Judgment - Judgment on Consent

JudgesIrene M. Keeley

Plaintiff

Celgene

Defendant

Viatris Inc.

Related Patents

Doc No Title Issue date
09101621 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation Aug 11, 2015
09101622 Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone Aug 11, 2015
09056120 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine Jun 16, 2015
08648095 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor Feb 11, 2014
08530498 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione Sep 10, 2013
08404717 Methods of treating myelodysplastic syndromes using lenalidomide Mar 26, 2013
07968569 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione Jun 28, 2011
07855217 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Dec 21, 2010
07465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Dec 16, 2008
07189740 Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes Mar 13, 2007
Menu